Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Study on the Home Treatment of Haemarthrosis With rFVIIa (Activated Recombinant Factor VII) in Haemophilia A and B Patients With Inhibitors

NCT01234545 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01234545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01234545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Study on the Home Treatment of Haemarthrosis With rFVIIa (Activated Recombinant Factor VII) in Haemophilia A and B Patients With Inhibitors
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
October 31, 2010
Completion date
April 30, 2012
Enrollment
35 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

congenital bleeding disorder, haemophilia a, haemophilia b